Q&A on Reducing COVID-19 Risk for Elderly, Immunocompromised factcheck.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from factcheck.org Daily Mail and Mail on Sunday newspapers.
More than 1 million people vaccinated with Pfizer or Moderna’s COVID-19 shots went back for a third dose ahead of any OK from regulators, according to a report citing estimates from the Centers for Disease Control and Prevention (CDC).
The US has paused its use of J&J s COVID-19 shot. How will that impact vaccine equity? Nada Hassanein, USA TODAY
Replay Video UP NEXT
Public health experts worry the pause on administering the Johnson & Johnson COVID-19 vaccine will impact efforts to reach marginalized, vulnerable populations including communities of color.
The one-and-done nature of the J&J COVID-19 shot, and less stringent storage requirements, made it ideal for homebound people, those in underserved neighborhoods and rural, remote areas with limited health care access. The other two authorized COVID-19 vaccines, from Pfizer-BioNTech and Moderna, require a second dose and more complicated cold storage.